Cardiac commitment driven by MyoD expression in pericardial stem cells.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Cardiovascular Research

Background:

• Cellular therapy for myocardial repair faces challenges due to limited sources of suitable cardiac cells.
• Stable engraftment of transplanted cells in the recipient heart remains a significant hurdle.

Purpose of the Study:

• To identify and characterize novel stem cell populations for cardiac regeneration.
• To investigate the potential of pericardial stem cells (pSCs) for myocardial repair after infarction.

Main Methods:

• Isolation and activation of pSCs from infarcted rat hearts (MI-pSCs).
• Assessment of cardiac commitment using gene expression (Tnnt2) and functional assays (rhythmic contraction).
• Bulk RNA-sequencing to analyze gene expression profiles of activated pSCs.
• Investigating the role of MyoD in cardiac commitment via siRNA-mediated gene silencing.
• Evaluating the in vivo engraftment and survival of cardiac-committed pSCs in infarcted rat hearts.

Main Results:

• MI-pSCs exhibited robust in vitro and in vivo cardiac commitment.
• Activated pSCs showed upregulated genes involved in cardiac differentiation, paracrine signaling, and extracellular matrix remodeling.
• MyoD was identified as a critical regulator of pSC cardiac commitment.
• Transplanted cardiac-committed pSCs demonstrated long-term survival and stable engraftment in the infarcted myocardium.

Conclusions:

• Pericardial tissue harbors myogenic stem cells (pSCs) that can be activated and committed to a cardiac lineage following myocardial infarction.
• MyoD plays a crucial role in mediating the cardiac differentiation of pSCs.
• Cardiac-committed pSCs represent a promising and accessible cell source for myocardial regeneration and cardiac cell-based therapies.